Breaking News

Over a quarter ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Plus Therapeutics intends to effect 1-for-50 reverse stock split » 07:51
07/29/19
07/29
07:51
07/29/19
07:51
CYTX

Cytori Therapeutics

$0.00 /

+ (+0.00%)

, PSTV

Plus Therapeutics

$0.21 /

-0.0069 (-3.19%)

The Company intends to…

The Company intends to effect a 1-for-50 reverse stock split to become effective on August 5, 2019, and the Company's common stock is expected to commence trading on a post-split basis beginning on August 6, 2019. The Company received the requisite stockholder approval for the reverse stock split on July 11, 2019. The new CUSIP number for the Company's common stock after the reverse stock split will be 72941H400. The reverse stock split will automatically combine every 50 shares of the Company's common stock into one issued and outstanding share without any change in the par value of the shares. Following the reverse stock split, the number of outstanding shares of the Company's common stock is anticipated to be proportionally reduced from approximately 22.2M to approximately 0.4M. As previously announced, the Company is required to evidence compliance with Nasdaq's minimum bid or closing price requirement by August 26, 2019. Although the Company expects that the reverse stock split will enable the Company to comply with the Nasdaq listing and minimum bid price requirement, there can be no assurance that the Company will be able to regain such compliance. Delisting from the Nasdaq Capital Market could have a material adverse effect on the Company's business and on the trading of its common stock.

ShowHide Related Items >><<
CYTX Cytori Therapeutics
$0.00 /

+ (+0.00%)

11/15/18 H.C. Wainwright
Cytori Therapeutics price target lowered to $3 from $5 at H.C. Wainwright
08/15/18 Maxim
Cytori Therapeutics downgraded to Hold at Maxim on capital concerns
08/15/18 H.C. Wainwright
Cytori Therapeutics price target lowered to $5.00 from $6.00 at H.C. Wainwright
08/15/18 Maxim
Cytori Therapeutics downgraded to Hold from Buy at Maxim
PSTV Plus Therapeutics
$0.21 /

-0.0069 (-3.19%)

Hot Stocks
Cytori Therapeutics officially changes name to Plus Therapeutics » 07:50
07/29/19
07/29
07:50
07/29/19
07:50
CYTX

Cytori Therapeutics

$0.21 /

-0.0069 (-3.19%)

, PSTV

Plus Therapeutics

$0.21 /

-0.0069 (-3.19%)

Plus Therapeutics…

Plus Therapeutics announced that the Company has officially changed its name from "Cytori Therapeutics, Inc." to "Plus Therapeutics, Inc." and the ticker symbol for the Company's common stock on the Nasdaq Capital Market will change from "CYTX" to "PSTV". The ticker symbol for the Company's Series S Warrants will change from "CYTXZ" to "PSTVZ". Trading under the new ticker symbols will begin at the open of the market on Monday, July 29, 2019. In addition, a new CUSIP number, 72941H103, has been assigned to the Company's common stock and the new CUSIP number assigned to the Company's Series S Warrants is 72941H111.

ShowHide Related Items >><<
CYTX Cytori Therapeutics
$0.21 /

-0.0069 (-3.19%)

11/15/18 H.C. Wainwright
Cytori Therapeutics price target lowered to $3 from $5 at H.C. Wainwright
08/15/18 Maxim
Cytori Therapeutics downgraded to Hold at Maxim on capital concerns
08/15/18 H.C. Wainwright
Cytori Therapeutics price target lowered to $5.00 from $6.00 at H.C. Wainwright
08/15/18 Maxim
Cytori Therapeutics downgraded to Hold from Buy at Maxim
PSTV Plus Therapeutics
$0.21 /

-0.0069 (-3.19%)

Conference/Events
Cytori Therapeutics to hold a webcast » 15:55
07/15/19
07/15
15:55
07/15/19
15:55
CYTX

Cytori Therapeutics

$0.27 /

+0.0326 (+13.87%)

Management discusses the…

Management discusses the company's new direction following two recent asset sales on a webcast to be held on July 15 at 4:30 pm. Webcast Link

ShowHide Related Items >><<
CYTX Cytori Therapeutics
$0.27 /

+0.0326 (+13.87%)

11/15/18 H.C. Wainwright
Cytori Therapeutics price target lowered to $3 from $5 at H.C. Wainwright
08/15/18 Maxim
Cytori Therapeutics downgraded to Hold at Maxim on capital concerns
08/15/18 H.C. Wainwright
Cytori Therapeutics price target lowered to $5.00 from $6.00 at H.C. Wainwright
08/15/18 Maxim
Cytori Therapeutics downgraded to Hold from Buy at Maxim
Conference/Events
Cytori Therapeutics to hold a webcast » 04:55
07/15/19
07/15
04:55
07/15/19
04:55
CYTX

Cytori Therapeutics

$0.24 /

+0.005 (+2.17%)

Management discusses the…

Management discusses the company's new direction following two recent asset sales on a webcast to be held on July 15 at 4:30 pm. Webcast Link

ShowHide Related Items >><<
CYTX Cytori Therapeutics
$0.24 /

+0.005 (+2.17%)

11/15/18 H.C. Wainwright
Cytori Therapeutics price target lowered to $3 from $5 at H.C. Wainwright
08/15/18 Maxim
Cytori Therapeutics downgraded to Hold at Maxim on capital concerns
08/15/18 H.C. Wainwright
Cytori Therapeutics price target lowered to $5.00 from $6.00 at H.C. Wainwright
08/15/18 Maxim
Cytori Therapeutics downgraded to Hold from Buy at Maxim
Conference/Events
Cytori Therapeutics to hold a webcast » 11:52
07/12/19
07/12
11:52
07/12/19
11:52
CYTX

Cytori Therapeutics

$0.23 /

+ (+0.00%)

Management discusses the…

Management discusses the company's new direction following two recent asset sales on a webcast to be held on July 15 at 4:30 pm. Webcast Link

ShowHide Related Items >><<
CYTX Cytori Therapeutics
$0.23 /

+ (+0.00%)

11/15/18 H.C. Wainwright
Cytori Therapeutics price target lowered to $3 from $5 at H.C. Wainwright
08/15/18 Maxim
Cytori Therapeutics downgraded to Hold at Maxim on capital concerns
08/15/18 H.C. Wainwright
Cytori Therapeutics price target lowered to $5.00 from $6.00 at H.C. Wainwright
08/15/18 Maxim
Cytori Therapeutics downgraded to Hold from Buy at Maxim

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.